Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -9.05 % |
3 Month Return | -3.25 % |
1 Year Return | + 1.05 % |
Market Stats | |
Previous Close | ₹59.72 |
Open | ₹59.70 |
Volume | 7,288.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹74.20Cr |
P/E Ratio | 111.2 |
PEG Ratio | 21.72 |
Market Cap | ₹74.20 Cr |
P/B Ratio | 1.31 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Chemicals |
ROE | 1.87 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹74.20 Cr | 50.32% | 0.50 | -₹4 Cr | ₹10 Cr | |
NA | ₹2,864.75 Cr | 125.52% | 0.55 | NA | NA | |
BUY | ₹16,189.37 Cr | 235.95% | 0.56 | ₹457 Cr | ₹8,696 Cr | |
NA | ₹208.90 Cr | 47.19% | 0.71 | NA | NA | |
NA | ₹506.47 Cr | 69.06% | 0.50 | ₹15 Cr | ₹104 Cr |
Organisation | Eiko Lifesciences Ltd |
Headquarters | |
Industry | Chemicals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, BASF India Ltd has given 120.1% return, outperforming this stock by 119.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 24.40% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, BASF India Ltd has given 122.5% return, outperforming this stock by 145.5%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 75.60% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, Eiko Lifescience stock has moved down by -7.9%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 24.4% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 75.6% | 0.00 | |
Others | 0% | 0.00 |
Eiko Lifesciences Ltd in the last 5 years
Lowest (-109.77x)
July 11, 2024
Industry (56.84x)
November 14, 2024
Today (111.20x)
November 14, 2024
Highest (131.43x)
October 11, 2024
Eiko Lifesciences Ltd’s net profit jumped 92.96% since last year same period to ₹0.05Cr in the Q2 2020-2021. On a quarterly growth basis, Eiko Lifesciences Ltd has generated -183.33% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2017, Eiko Lifesciences Ltd has declared dividend of ₹0.25 - translating a dividend yield of 0.42%.
Read More about DividendsBearish
Neutral
Bullish
Eiko Lifesciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Eiko Lifesciences Ltd (540204) share price today is ₹59.99
Eiko Lifesciences Ltd is not listed on NSE
Eiko Lifesciences Ltd is listed on BSE
PE Ratio of Eiko Lifesciences Ltd is 111.2
PE ratio = Eiko Lifesciences Ltd Market price per share / Eiko Lifesciences Ltd Earnings per share
Today’s traded volume of Eiko Lifesciences Ltd(540204) is 7,288.00.
Today’s market capitalisation of Eiko Lifesciences Ltd(540204) is ₹74.2Cr.
Eiko Lifesciences Ltd(540204 | Price |
---|---|
52 Week High | ₹81.32 |
52 Week Low | ₹45.1 |
Eiko Lifesciences Ltd(540204) share price is ₹59.99. It is down -26.23% from its 52 Week High price of ₹81.32
Eiko Lifesciences Ltd(540204) share price is ₹59.99. It is up 33.02% from its 52 Week Low price of ₹45.1
Eiko Lifesciences Ltd(540204 | Returns |
---|---|
1 Day Returns | 0.27% |
1 Month Returns | -9.05% |
3 Month Returns | -3.25% |
1 Year Returns | 1.05% |